Statin, testosterone and phosphodiesterase 5-inhibitor treatments and age related mortality in diabetes

doi:10.4239/wjd.v8.i3.104

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (12008)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

561

WORD

328

HTML

5015

Figures (1-3)

258

Tables (1-2)

248

Sum=6410

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

803

Download

1902

Sum=2705

Publishing Process of This Article

Item

Count

Browse

1049

Download

1844

Sum=2893

Mar 15, 2017 (publication date) through Dec 26, 2024

Times Cited of This Article

Times Cited (42)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Diabetes. Mar 15, 2017; 8(3): 104-111
Published online Mar 15, 2017. doi: 10.4239/wjd.v8.i3.104

Full Size Figure Download Figure

Figure 1 Association between Ln (mortality rate) and age.

Citation: Hackett G, Jones PW, Strange RC, Ramachandran S. Statin, testosterone and phosphodiesterase 5-inhibitor treatments and age related mortality in diabetes. World J Diabetes 2017; 8(3): 104-111
URL: https://www.wjgnet.com/1948-9358/full/v8/i3/104.htm
DOI: https://dx.doi.org/10.4239/wjd.v8.i3.104